← FDA Drug Approvals (Drugs@FDA)

REZUROCK

NDA · New Drug Application · Sponsor: KADMON PHARMS LLC · Approved 2021-07-16

Drug application

FDA Application #

NDA214783

Application type

New Drug Application

Brand name

REZUROCK

Generic name

BELUMOSUDIL

Active ingredients

BELUMOSUDIL MESYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

KADMON PHARMS LLC

Manufacturer

Kadmon Pharmaceuticals, LLC

First approval

2021-07-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown